Viagra
Clinical Study Results
In clinical studies, VIAGRA was assessed for its effect on the
ability of men with erectile
dysfunction (ED) to engage in sexual activity and in many cases
specifically on the ability to
achieve and maintain an erection sufficient for satisfactory sexual
activity.
VIAGRA
was evaluated primarily at doses of 25 mg, 50 mg and 100 mg in
21 randomized,
double-blind,
placebo-controlled trials of up to 6 months in duration, using
a variety of study designs (fixed
dose, titration, parallel, crossover).
VIAGRA
was administered to more than 3,000 patients aged 19 to 87 years,
with ED of various etiologies (organic, psychogenic, mixed) with
a mean duration of 5 years. VIAGRA demonstrated statistically significant
improvement compared to placebo in all 21 studies.
The
studies that established benefit demonstrated improvements in
success rates for sexual intercourse compared with placebo. The
effectiveness of VIAGRA was evaluated in most studies using several
assessment instruments.
The
primary measure in the principal studies was a sexual function
questionnaire (the International
Index of Erectile Function - IIEF) administered during a 4-week
treatment-free run-in period, at baseline, at follow-up visits,
and at the end of double-blind, placebo-controlled, at-home
treatment.
Two
of the questions from the IIEF served as primary study endpoints;
categorical responses were elicited to questions about
(1)
the ability to achieve erections sufficient for sexual intercourse
and
(2)
the maintenance of erections after penetration. The patient
addressed both questions at the final visit for the last
4
weeks of the study.
The
possible categorical responses to these questions
were:
- no attempted intercourse
- never
or almost never
- a
few times
- sometimes
- most
times
- almost
always or always
Also
collected as part of the IIEF was information about other aspects
of sexual function,
including
7 information
on erectile function, orgasm, desire,
satisfaction with intercourse, and overall sexual satisfaction.
Sexual
function data were also recorded by patients in a daily diary.
In addition, patients were asked a global efficacy question
and an
optional partner
questionnaire was administered.
Results
with all doses have been pooled, but scores showed greater
improvement
at
the 50
and 100
mg doses than at 25 mg. The pattern
of responses
was similar for the other principal question,
the ability to
achieve
an erection sufficient for intercourse.
The
titration studies, in which most
patients received 100 mg, showed
similar results. Regardless of the
baseline levels of
function, subsequent function in patients treated
with
VIAGRA was
better
than
that
seen in patients treated with
placebo. At the same time,
on-treatment function was better
in treated patients who were
less impaired
at baseline.
| |
|
|
Viagra
Directions & Ordering from KWIKMED
-
KwikMed
is the ONLY company granted regulatory approval to
offer prescriptions with an online diagnosis.
-
KwikMed
uses only licensed physicians to evaluate each patient’s
needs using an online diagnostic assessment and interactive
follow-up whenever required.
-
KwikMed
uses only licensed pharmacists to fill prescriptions
with FDA-approved medications.
- Click
Here For Viagra Online For Erectile
Dysfunction
|
|
 |
|